2024

1. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

   Endocrine-related cancer

2. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

   European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

3. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

   Pituitary, Vol. 27, Núm. 5, pp. 497-506

4. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

   Endocrine-Related Cancer, Vol. 31, Núm. 7